NCT01653678 - Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension) | Biotech Hunter

Enrollment

25,875

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

September 30, 2025

Study Completion Date

January 31, 2026

Conditions

Hypertension

Interventions

DIETARY_SUPPLEMENT

Vitamin D-3 (cholecalciferol), 2000 IU

DRUG

Omega-3 fatty acids (fish oil)

Omacor, 1 capsule per day. Each capsule of Omacor contains 840 milligrams of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid \[EPA\] and 375 mg of docosahexaenoic acid \[DHA\])

DIETARY_SUPPLEMENT

Vitamin D placebo

DRUG

Fish oil placebo

Trial Locations (1)

02215

Brigham and Women's Hospital, Boston

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Brigham and Women's Hospital

OTHER